Skip to main content
Erschienen in: Journal of Genetic Counseling 3/2018

27.10.2017 | Original Research

Parent Perspectives of Support Received from Physicians and/or Genetic Counselors Following a Decision to Continue a Pregnancy with a Prenatal Diagnosis of Trisomy 13/18

verfasst von: Stephanie E. Wallace, Sara Gilvary, Michael J. Smith, Siobhan M. Dolan

Erschienen in: Journal of Genetic Counseling | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Families that choose to continue a pregnancy with a prenatal diagnosis of Trisomy 13/18 are a minority that present unique challenges for those in charge of their care. This study investigated the extent to which these patients felt supported by their healthcare providers, and any differences in the perceived level of support experienced by those working with a physician versus those working with a genetic counselor. Two online support groups, SOFT and Hope for Trisomy, distributed an online survey to their members. Means, standard deviations and chi-square analysis were calculated to describe their responses. One-hundred fourteen surveys were included in the final analysis. Respondents were more likely to agree that genetic counselors provided unbiased information in a way that they understood, compared to physicians. Review of qualitative responses found that portrayal of Trisomy 13/18 by healthcare providers used directive language when describing the lethality, morbidity and burden of the condition. Language included terms such as “incompatible with life” and comments on burden to other family members. Healthcare providers can assist families that receive a prenatal diagnosis of Trisomy 13 or 18 by providing up-to-date written resources and connecting them with support groups for parents who have received a similar diagnosis. Our study found that involving genetic counselors in the prenatal care of these patients is likely beneficial.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
Zurück zum Zitat American College of Obstetricians and Gynecologists (2007). Practice Bulletin Number 88: Clinical Management Guidelines for Obstetricians-Gynecologists. Washington DC: ACOG. American College of Obstetricians and Gynecologists (2007). Practice Bulletin Number 88: Clinical Management Guidelines for Obstetricians-Gynecologists. Washington DC: ACOG.
Zurück zum Zitat American Heart Association. (2010). Neonatal resuscitation: 2010 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Pediatrics, 126, e1400–e1413.CrossRef American Heart Association. (2010). Neonatal resuscitation: 2010 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Pediatrics, 126, e1400–e1413.CrossRef
Zurück zum Zitat Barry, S. C., Walsh, C. A., Burke, A. L., et al. (2015). Natural history of fetal trisomy 13 after prenatal diagnosis. American Journal of Medical Genetics. Part A, 167A, 147–150.CrossRefPubMed Barry, S. C., Walsh, C. A., Burke, A. L., et al. (2015). Natural history of fetal trisomy 13 after prenatal diagnosis. American Journal of Medical Genetics. Part A, 167A, 147–150.CrossRefPubMed
Zurück zum Zitat Baty, B. J., Blackburn, B. L., & Carey, J. C. (1994). Natural history of trisomy 18 and trisomy 13: Growth, physical assessment, medical histories, survival and recurrence risk. American Journal of Medical Genetics, 15, 175–188.CrossRef Baty, B. J., Blackburn, B. L., & Carey, J. C. (1994). Natural history of trisomy 18 and trisomy 13: Growth, physical assessment, medical histories, survival and recurrence risk. American Journal of Medical Genetics, 15, 175–188.CrossRef
Zurück zum Zitat Burke, A. L., Field, K., & Morrison, J. J. (2013). Natural history of fetal trisomy 18 after prenatal diagnosis. Archives of Disease in Childhood. Fetal and Neonatal Edition, 98, F152–F154.CrossRefPubMed Burke, A. L., Field, K., & Morrison, J. J. (2013). Natural history of fetal trisomy 18 after prenatal diagnosis. Archives of Disease in Childhood. Fetal and Neonatal Edition, 98, F152–F154.CrossRefPubMed
Zurück zum Zitat Castro, F. G., Kellison, J. G., Boyd, S. J., et al. (2010). A methodology for conducting integrative mixed Methods research and data analyses. Journal of Mixed Methods Research, 4, 342–360.CrossRefPubMedPubMedCentral Castro, F. G., Kellison, J. G., Boyd, S. J., et al. (2010). A methodology for conducting integrative mixed Methods research and data analyses. Journal of Mixed Methods Research, 4, 342–360.CrossRefPubMedPubMedCentral
Zurück zum Zitat Center for Disease Control (2014) Births: Preliminary data 2014. National Vital Statistics Reports (62). Hyattsville: National Center for Health Statistics. Center for Disease Control (2014) Births: Preliminary data 2014. National Vital Statistics Reports (62). Hyattsville: National Center for Health Statistics.
Zurück zum Zitat Chervanak, F. (2009). An ethically justified practical approach to offering, recommending, performing and referring for induced abortion and feticide. American Journal of Obstetrics and Gynecology, 201, e1–e6. Chervanak, F. (2009). An ethically justified practical approach to offering, recommending, performing and referring for induced abortion and feticide. American Journal of Obstetrics and Gynecology, 201, e1–e6.
Zurück zum Zitat Chervenak, F., & McCullough, L. B. (2012). Responsibly counselling women about the clinical management of pregnancies complicated by severe fetal anomalies. Journal of Medical Ethics, 38, 397.CrossRefPubMed Chervenak, F., & McCullough, L. B. (2012). Responsibly counselling women about the clinical management of pregnancies complicated by severe fetal anomalies. Journal of Medical Ethics, 38, 397.CrossRefPubMed
Zurück zum Zitat Guon, J., Wilfond, B. S., Farlow, B., et al. (2014). Our children are not a diagnosis: The experience of parents who continue their pregnancy after a prenatal diagnosis of trisomy 13 or 18. American Journal of Medical Genetics: Part A, 164A, 308–318.CrossRef Guon, J., Wilfond, B. S., Farlow, B., et al. (2014). Our children are not a diagnosis: The experience of parents who continue their pregnancy after a prenatal diagnosis of trisomy 13 or 18. American Journal of Medical Genetics: Part A, 164A, 308–318.CrossRef
Zurück zum Zitat Hawkins, A., Stenzel, A., Taylro, J., et al. (2013). Variables influencing pregnancy termination following prenatal diagnosis of fetal chromosome abnormalities. Journal of Genetic Counseling, 22, 238–248.CrossRefPubMed Hawkins, A., Stenzel, A., Taylro, J., et al. (2013). Variables influencing pregnancy termination following prenatal diagnosis of fetal chromosome abnormalities. Journal of Genetic Counseling, 22, 238–248.CrossRefPubMed
Zurück zum Zitat Heuser, C. (2012). Survey of physicians' approach to severe fetal anomalies. Journal of Medical Ethics, 38, 391–395.CrossRefPubMed Heuser, C. (2012). Survey of physicians' approach to severe fetal anomalies. Journal of Medical Ethics, 38, 391–395.CrossRefPubMed
Zurück zum Zitat Irving, C., Richmond, S., & Wren, C. (2011). Changes in fetal prevalence and outcomes for trisomies 13 and 18: A population based study over 23 years. The Journal of Maternal-Fetal & Neonatal Medicine, 24, 137–141.CrossRef Irving, C., Richmond, S., & Wren, C. (2011). Changes in fetal prevalence and outcomes for trisomies 13 and 18: A population based study over 23 years. The Journal of Maternal-Fetal & Neonatal Medicine, 24, 137–141.CrossRef
Zurück zum Zitat Janvier, A., Farlow, B., & Wilfond, B. (2012). The experiences of families with children with trisomy 13 and 18 in social networks. Pediatrics, 130, 293–298.CrossRefPubMed Janvier, A., Farlow, B., & Wilfond, B. (2012). The experiences of families with children with trisomy 13 and 18 in social networks. Pediatrics, 130, 293–298.CrossRefPubMed
Zurück zum Zitat Kim, Y. J., Lee, J. E., Kim, S. H., et al. (2013). Maternal age specific rates of fetal chromosomal abnormalities in Korean pregnant women of advanced maternal age. Obstetrics & Gynecology Science, 56, 160–166.CrossRef Kim, Y. J., Lee, J. E., Kim, S. H., et al. (2013). Maternal age specific rates of fetal chromosomal abnormalities in Korean pregnant women of advanced maternal age. Obstetrics & Gynecology Science, 56, 160–166.CrossRef
Zurück zum Zitat Koogler, T. K., Wilfond, B. S., & Friedman Ross, L. (2003). Lethal language, lethal decisions. The Hastings Center Report, 33, 37–41.CrossRefPubMed Koogler, T. K., Wilfond, B. S., & Friedman Ross, L. (2003). Lethal language, lethal decisions. The Hastings Center Report, 33, 37–41.CrossRefPubMed
Zurück zum Zitat Kosho, T., Nakamura, T., Kawame, H., et al. (2006). Neonatal management of trisomy 18: Clinical details of 24 patients receiving intensive treatment. American Journal of Medical Genetics Part A, 140A, 937–944.CrossRef Kosho, T., Nakamura, T., Kawame, H., et al. (2006). Neonatal management of trisomy 18: Clinical details of 24 patients receiving intensive treatment. American Journal of Medical Genetics Part A, 140A, 937–944.CrossRef
Zurück zum Zitat Lantos, J. D. (2016). Trisomy 13 and 18 – Treatment decisions in a stable gray zone. JAMA, 316, 396–398.CrossRefPubMed Lantos, J. D. (2016). Trisomy 13 and 18 – Treatment decisions in a stable gray zone. JAMA, 316, 396–398.CrossRefPubMed
Zurück zum Zitat McGraw, M., & Perlman, J. (2008). Attitudes of neonatologists toward delivery room management of confirmed trisomy 18: Potential factors influencing a changing dynamic. Pediatrics, 121, 1106.CrossRefPubMed McGraw, M., & Perlman, J. (2008). Attitudes of neonatologists toward delivery room management of confirmed trisomy 18: Potential factors influencing a changing dynamic. Pediatrics, 121, 1106.CrossRefPubMed
Zurück zum Zitat Morris, J., & Savva, G. M. (2008). The risk of fetal loss following a prenatal diagnosis of trisomy 13 or trisomy 18. American Journal of Medical Genetics. Part A, 146A, 827–832.CrossRefPubMed Morris, J., & Savva, G. M. (2008). The risk of fetal loss following a prenatal diagnosis of trisomy 13 or trisomy 18. American Journal of Medical Genetics. Part A, 146A, 827–832.CrossRefPubMed
Zurück zum Zitat Nelson, K. E., Rosella, L. C., Mahant, S., et al. (2016). Survival and surgical interventions for children with trisomy 13 and 18. JAMA, 316, 420–428.CrossRefPubMed Nelson, K. E., Rosella, L. C., Mahant, S., et al. (2016). Survival and surgical interventions for children with trisomy 13 and 18. JAMA, 316, 420–428.CrossRefPubMed
Zurück zum Zitat Parker, S. E., Mai, C. T., Canfield, M. A., et al. (2010). Updated national birth prevalence estimates for selected birth defects in the united states,2004-2006. Birth Defects Research. Part A, Clinical and Molecular Teratology, 88, 1008.CrossRefPubMed Parker, S. E., Mai, C. T., Canfield, M. A., et al. (2010). Updated national birth prevalence estimates for selected birth defects in the united states,2004-2006. Birth Defects Research. Part A, Clinical and Molecular Teratology, 88, 1008.CrossRefPubMed
Zurück zum Zitat Rasmussen, S. A., Wong, L. Y., Yang, Q., et al. (2003). Population-based analysis of mortality in trisomy 13 and 18. Pediatrics, 111, 777–784.CrossRefPubMed Rasmussen, S. A., Wong, L. Y., Yang, Q., et al. (2003). Population-based analysis of mortality in trisomy 13 and 18. Pediatrics, 111, 777–784.CrossRefPubMed
Zurück zum Zitat Redlinger-Grosse, K., Bernhardt, B. A., Berg, K., Muenke, M., & Beisecker, B. B. (2002). The decision to continue: The experience and needs of parents who receive a prenatal diagnosis of holoprosencephaly. American Journal of Medical Genetics, 112, 369–379.CrossRefPubMed Redlinger-Grosse, K., Bernhardt, B. A., Berg, K., Muenke, M., & Beisecker, B. B. (2002). The decision to continue: The experience and needs of parents who receive a prenatal diagnosis of holoprosencephaly. American Journal of Medical Genetics, 112, 369–379.CrossRefPubMed
Zurück zum Zitat Skotko, B. G. (2005). Prenatally diagnosed down syndrome: Mothers who continued their pregnancies evaluate their health care providers. American Journal of Obstetrics and Gynecology, 192, 670–677.CrossRefPubMed Skotko, B. G. (2005). Prenatally diagnosed down syndrome: Mothers who continued their pregnancies evaluate their health care providers. American Journal of Obstetrics and Gynecology, 192, 670–677.CrossRefPubMed
Zurück zum Zitat Walker, L. V., Miller, V. J., & Dalton, V. K. (2008). The health-care experiences of families given the prenatal diagnosis of trisomy 18. Journal of Perinatology, 28, 12–19.CrossRefPubMed Walker, L. V., Miller, V. J., & Dalton, V. K. (2008). The health-care experiences of families given the prenatal diagnosis of trisomy 18. Journal of Perinatology, 28, 12–19.CrossRefPubMed
Zurück zum Zitat Wilkinson, D. J., Crespigny, L., Lees, C., et al. (2014). Perinatal management of trisomy 18: A survey of obstetricians in Australia, New Zealand and the UK. Prenatal Diagnosis, 34, 42–49.CrossRefPubMed Wilkinson, D. J., Crespigny, L., Lees, C., et al. (2014). Perinatal management of trisomy 18: A survey of obstetricians in Australia, New Zealand and the UK. Prenatal Diagnosis, 34, 42–49.CrossRefPubMed
Zurück zum Zitat Yates, A. R. (2011). Pediatric sub-specialtist controversies in treatment of congenital heart disease in trisomy 13 or 18. Journal of Genetic Counseling, 20, 495–509.CrossRefPubMed Yates, A. R. (2011). Pediatric sub-specialtist controversies in treatment of congenital heart disease in trisomy 13 or 18. Journal of Genetic Counseling, 20, 495–509.CrossRefPubMed
Metadaten
Titel
Parent Perspectives of Support Received from Physicians and/or Genetic Counselors Following a Decision to Continue a Pregnancy with a Prenatal Diagnosis of Trisomy 13/18
verfasst von
Stephanie E. Wallace
Sara Gilvary
Michael J. Smith
Siobhan M. Dolan
Publikationsdatum
27.10.2017
Verlag
Springer US
Erschienen in
Journal of Genetic Counseling / Ausgabe 3/2018
Print ISSN: 1059-7700
Elektronische ISSN: 1573-3599
DOI
https://doi.org/10.1007/s10897-017-0168-6

Weitere Artikel der Ausgabe 3/2018

Journal of Genetic Counseling 3/2018 Zur Ausgabe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.